But is it normal that the public, who bears the costs, does not have any insight into the contracts and their terms? No, thinks Yannis Natsis, of the European Public Health Alliance, which defends the rights of patients and stands up for affordable medicines. “It’s alarming.”
According to him, the pharmaceutical companies collect so much money that they should at least be transparent. “We are committed to buying those vaccines once they are there, so we offer pharmaceutical companies a lot of certainty, but we don’t have any insight into the details of the contracts. We don’t know what’s going on behind closed doors.”
(Read more below the video)
–
